Ur-Energy Valuation

Is U9T undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of U9T when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: U9T (€1.04) is trading below our estimate of fair value (€6.58)

Significantly Below Fair Value: U9T is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for U9T?

Other financial metrics that can be useful for relative valuation.

U9T key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue22.9x
Enterprise Value/EBITDA-8.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does U9T's PS Ratio compare to its peers?

The above table shows the PS ratio for U9T vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.1x
ETG EnviTec Biogas
1.1xn/a€466.3m
DR0 Deutsche Rohstoff
0.7x-3.6%€168.7m
VH2 Friedrich Vorwerk Group
1.2x9.7%€484.0m
URC Uranium Royalty
9.4xn/aCA$402.2m
U9T Ur-Energy
26.7x41.4%€572.4m

Price-To-Sales vs Peers: U9T is expensive based on its Price-To-Sales Ratio (26.7x) compared to the peer average (3.1x).


Price to Earnings Ratio vs Industry

How does U9T's PE Ratio compare vs other companies in the European Oil and Gas Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a1.9%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a1.9%
n/an/an/a
No more companies

Price-To-Sales vs Industry: U9T is expensive based on its Price-To-Sales Ratio (26.7x) compared to the European Oil and Gas industry average (1.2x).


Price to Sales Ratio vs Fair Ratio

What is U9T's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

U9T PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio26.7x
Fair PS Ratio0.001x

Price-To-Sales vs Fair Ratio: U9T is expensive based on its Price-To-Sales Ratio (26.7x) compared to the estimated Fair Price-To-Sales Ratio (0x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst U9T forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.04
€2.54
+143.9%
28.5%€3.26€1.81n/a2
Sep ’25€1.03
€2.54
+147.4%
28.5%€3.26€1.81n/a2
Aug ’25€1.17
€2.85
+143.3%
35.4%€3.86€1.84n/a2
Jul ’25€1.28
€2.88
+124.7%
35.1%€3.89€1.87n/a2
Jun ’25€1.64
€2.88
+75.4%
35.4%€3.90€1.86n/a2
May ’25€1.61
€2.93
+82.5%
36.1%€3.99€1.87n/a2
Apr ’25€1.50
€2.91
+93.5%
35.7%€3.94€1.87n/a2
Mar ’25€1.49
€2.93
+96.3%
35.2%€3.96€1.90n/a2
Feb ’25€1.81
€2.66
+47.4%
29.0%€3.44€1.89n/a2
Jan ’25€1.34
€2.62
+95.0%
28.3%€3.36€1.88n/a2
Dec ’24€1.45
€2.62
+80.2%
28.3%€3.36€1.88n/a2
Nov ’24€1.56
€2.64
+69.2%
29.0%€3.40€1.87n/a2
Oct ’24€1.55
€2.37
+53.4%
35.7%€3.22€1.52n/a2
Sep ’24€1.19
€2.37
+98.6%
35.7%€3.22€1.52€1.032
Aug ’24€0.96
€2.42
+153.1%
35.0%€3.27€1.58€1.172
Jul ’24€0.95
€2.42
+155.2%
35.0%€3.27€1.58€1.282
Jun ’24€0.83
€2.41
+189.7%
35.7%€3.27€1.55€1.642
May ’24€0.80
€2.38
+197.9%
36.3%€3.24€1.51€1.612
Apr ’24€0.88
€2.55
+188.6%
40.4%€3.58€1.52€1.502
Mar ’24€1.00
€2.62
+162.9%
39.7%€3.66€1.58€1.492
Feb ’24€1.18
€2.53
+114.5%
39.3%€3.52€1.54€1.812
Jan ’24€1.05
€2.59
+146.3%
40.0%€3.62€1.55€1.342
Dec ’23€1.25
€2.77
+122.0%
42.3%€3.95€1.60€1.452
Nov ’23€1.32
€2.90
+119.5%
42.4%€4.12€1.67€1.562

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies